Skip to content

Treatment / Procedure

Bodrum Biotin IV | Evidence and Laboratory Safety

Short answerBiotin deficiency is rare. There is no strong clinical evidence supporting the routine use of IV biotin for hair, skin, or energy purposes. Eligibility is determined through medical history, laboratory requirements, product content, and safety assessment.

← Main guide to IV and Infusion Therapies

What is Biotin IV?

Biotin deficiency is rare. There is no strong clinical evidence supporting the routine use of IV biotin for hair, skin, or energy purposes.

How does it work?

It participates in fatty acid, amino acid, and glucose metabolism as a cofactor in carboxylase enzymes.

In which situations can it be considered?

It should be evaluated only in the presence of documented deficiency or specific metabolic needs, after verifying the preparation and route of administration.

Level of evidence

C-D – limited or experimental.

Safety and patient selection

High biotin exposure can interfere with many laboratory results, including thyroid, troponin, and hormone tests. Its use must be reported prior to testing.

Our Approach at Our Bodrum Clinic

We consider this administration only after verifying the pharmaceutical properties of the product and evaluating the patient’s medical history, current medications, kidney and liver functions, necessary electrolyte and micronutrient measurements, and relevant contraindications. We plan IV therapy not as an alternative to standard treatment, but as a complementary or replacement approach when a genuine clinical justification exists.

Important note

This page is for general informational purposes only; it is not a personal diagnosis, prescription, or administration protocol. Administration should not be planned without verifying the label, concentration, excipient, licensing, stability, and compatibility information of the IV product.

Explore all IV and infusion therapies

Medical editorial information

This content has been medically reviewed and approved by Dr. Kerem Çağlayan. It is intended for general education and does not replace an individual diagnosis or treatment plan.

References

  1. https://ods.od.nih.gov/factsheets/Biotin-HealthProfessional/ https://www.fda.gov/medical-devices/safety-communications/update-fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication